Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Exp Cell Res ; 415(1): 113106, 2022 06 01.
Article in English | MEDLINE | ID: mdl-35307409

ABSTRACT

Invasive melanoma is an aggressive form of skin cancer with high incidence of mortality. The process of tumor invasion is a crucial primary step in the metastatic cascade, yet the mechanisms involved are still under investigation. Here we document a critical role for MLK3 (MAP3K11) in the regulation of melanoma cell invasion. We report the unexpected finding that cellular loss of MLK3 in melanoma cells promotes cell invasion. Cellular depletion of MLK3 expression results in the hyperactivation of ERK, which is linked to the formation of a BRAF/Hsp90/Cdc37 protein complex. ERK hyperactivation leads to enhanced phosphorylation and inactivation of GSK3ß and the stabilization of c-Jun and JNK activity. Blocking of ERK and JNK signaling as well as Hsp90 activity downstream of MLK3-silencing significantly reduces melanoma invasion. Furthermore, ERK activation in the aforementioned context is coupled to MT1-MMP transcription as well as the TOM1L1-dependent localization of the membrane protease to invadopodia at the invasive front. These studies provide critical insight into the mechanisms that couple MLK3 loss with BRAF hyperactivation and its consequence on melanoma invasion.


Subject(s)
MAP Kinase Kinase Kinases , Melanoma , Adaptor Proteins, Signal Transducing/metabolism , Cell Line, Tumor , HSP90 Heat-Shock Proteins/metabolism , Humans , MAP Kinase Kinase Kinases/metabolism , MAP Kinase Signaling System , Melanoma/genetics , Phosphorylation , Proto-Oncogene Proteins B-raf/genetics , Proto-Oncogene Proteins B-raf/metabolism
2.
J Biol Chem ; 297(5): 101266, 2021 11.
Article in English | MEDLINE | ID: mdl-34600888

ABSTRACT

Functional delivery of mRNA has high clinical potential. Previous studies established that mRNAs can be delivered to cells in vitro and in vivo via RNA-loaded lipid nanoparticles (LNPs). Here we describe an alternative approach using exosomes, the only biologically normal nanovesicle. In contrast to LNPs, which elicited pronounced cellular toxicity, exosomes had no adverse effects in vitro or in vivo at any dose tested. Moreover, mRNA-loaded exosomes were characterized by efficient mRNA encapsulation (∼90%), high mRNA content, consistent size, and a polydispersity index under 0.2. Using an mRNA encoding the red light-emitting luciferase Antares2, we observed that mRNA-loaded exosomes were superior to mRNA-loaded LNPs at delivering functional mRNA into human cells in vitro. Injection of Antares2 mRNA-loaded exosomes also led to strong light emission following injection into the vitreous fluid of the eye or into the tissue of skeletal muscle in mice. Furthermore, we show that repeated injection of Antares2 mRNA-loaded exosomes drove sustained luciferase expression across six injections spanning at least 10 weeks, without evidence of signal attenuation or adverse injection site responses. Consistent with these findings, we observed that exosomes loaded with mRNAs encoding immunogenic forms of the SARS-CoV-2 Spike and Nucleocapsid proteins induced long-lasting cellular and humoral responses to both. Taken together, these results demonstrate that exosomes can be used to deliver functional mRNA to and into cells in vivo.


Subject(s)
Exosomes/immunology , RNA, Messenger/genetics , SARS-CoV-2/immunology , Cells, Cultured , Gene Transfer Techniques , HEK293 Cells , Humans , Lipids/chemistry , Nanoparticles/chemistry , RNA, Messenger/immunology , SARS-CoV-2/genetics
3.
Exp Cell Res ; 365(2): 194-207, 2018 04 15.
Article in English | MEDLINE | ID: mdl-29522754

ABSTRACT

Aberrant cellular cholesterol accumulation contributes to the pathophysiology of many diseases including neurodegenerative disorders such as Niemann-Pick Type C (NPC) and Alzheimer's Disease1-4. Many aspects of cholesterol efflux from cells remain elusive. Here we describe the utility of cholesterol-rich giant plasma membrane vesicles (GPMVs) as a means to monitor cholesterol that is translocated to the plasma membrane for secretion. We demonstrate that small molecules known to enhance lipid efflux, including those in clinical trials for lipid storage disorders, enhance this GPMV formation. Conversely, pharmacological inhibition of cholesterol efflux blocks GPMV formation. We show that microtubule stabilization via paclitaxel treatment and increased tubulin acetylation via HDAC6 inhibition promotes the formation of GPMVs with concomitant reduction in cellular cholesterol in a cell model of NPC disease. The pan-deacetylase inhibitor panobinostat, which has been shown to reduce the severity of cholesterol storage in NPC, elicited a similar response. Further, the disruption of actin polymerization inhibits the formation of GPMVs, whereas the small GTP-binding protein Arl4c promotes actin remodeling at sites overlapping with GPMV formation. Thus, monitoring the formation of GPMVs provides a new avenue to better understand diseases whose pathology may be sensitive to alterations in cellular cholesterol.


Subject(s)
Cell Membrane/metabolism , Cholesterol/metabolism , Exocytosis/physiology , Extracellular Vesicles/metabolism , Organelle Size/physiology , Biological Transport , Cell Line , Cell Membrane/pathology , Extracellular Vesicles/pathology , Humans , Lipid Metabolism/physiology , Optical Imaging
4.
Traffic ; 19(5): 319-327, 2018 05.
Article in English | MEDLINE | ID: mdl-29479795

ABSTRACT

The study of extracellular vesicles (EVs) is a rapidly evolving field, owing in large part to recent advances in the realization of their significant contributions to normal physiology and disease. Once discredited as cell debris, these membrane vesicles have now emerged as mediators of intercellular communication by interaction with target cells, drug and gene delivery, and as potentially versatile platforms of clinical biomarkers as a result of their distinctive protein, nucleic acid and lipid cargoes. While there are multiple classes of EVs released from almost all cell types, here we focus primarily on the biogenesis, fate and functional cargoes of microvesicles (MVs). MVs regulate many important cellular processes including facilitating cell invasion, cell growth, evasion of immune response, stimulating angiogenesis, drug resistance and many others.


Subject(s)
Extracellular Vesicles/metabolism , Animals , Biological Transport , Extracellular Vesicles/ultrastructure , Humans , Organelle Biogenesis
5.
Cancers (Basel) ; 8(9)2016 Aug 29.
Article in English | MEDLINE | ID: mdl-27589803

ABSTRACT

The importance of canonical and non-canonical Wnt signal transduction cascades in embryonic development and tissue homeostasis is well recognized. The aberrant activation of these pathways in the adult leads to abnormal cellular behaviors, and tumor progression is frequently a consequence. Here we discuss recent findings and analogies between Wnt signaling in developmental processes and tumor progression, with a particular focus on cell motility and matrix invasion and highlight the roles of the ARF (ADP-Ribosylation Factor) and Rho-family small GTP-binding proteins. Wnt-regulated signal transduction from cell surface receptors, signaling endosomes and/or extracellular vesicles has the potential to profoundly influence cell movement, matrix degradation and paracrine signaling in both development and disease.

6.
Sci Rep ; 5: 14748, 2015 Oct 13.
Article in English | MEDLINE | ID: mdl-26458510

ABSTRACT

Tumor cell invasion requires the molecular and physical adaptation of both the cell and its microenvironment. Here we show that tumor cells are able to switch between the use of microvesicles and invadopodia to facilitate invasion through the extracellular matrix. Invadopodia formation accompanies the mesenchymal mode of migration on firm matrices and is facilitated by Rac1 activation. On the other hand, during invasion through compliant and deformable environments, tumor cells adopt an amoeboid phenotype and release microvesicles. Notably, firm matrices do not support microvesicle release, whereas compliant matrices are not conducive to invadopodia biogenesis. Furthermore, Rac1 activation is required for invadopodia function, while its inactivation promotes RhoA activation and actomyosin contractility required for microvesicle shedding. Suppression of RhoA signaling blocks microvesicle formation but enhances the formation of invadopodia. Finally, we describe Rho-mediated pathways involved in microvesicle biogenesis through the regulation of myosin light chain phosphatase. Our findings suggest that the ability of tumor cells to switch between the aforementioned qualitatively distinct modes of invasion may allow for dissemination across different microenvironments.


Subject(s)
Cell-Derived Microparticles/metabolism , Neoplasms/metabolism , Neoplasms/pathology , Podosomes/metabolism , ADP-Ribosylation Factor 6 , ADP-Ribosylation Factors/metabolism , Cell Line, Tumor , Cell Movement , Extracellular Matrix/metabolism , Humans , Myosin Light Chains/metabolism , Myosin-Light-Chain Kinase/metabolism , Neoplasm Invasiveness , Phosphorylation , Signal Transduction , rac1 GTP-Binding Protein/metabolism , rho-Associated Kinases/metabolism , rhoA GTP-Binding Protein/metabolism
7.
Nat Commun ; 6: 6919, 2015 Apr 21.
Article in English | MEDLINE | ID: mdl-25897521

ABSTRACT

Cells release multiple, distinct forms of extracellular vesicles including structures known as microvesicles, which are known to alter the extracellular environment. Despite growing understanding of microvesicle biogenesis, function and contents, mechanisms regulating cargo delivery and enrichment remain largely unknown. Here we demonstrate that in amoeboid-like invasive tumour cell lines, the v-SNARE, VAMP3, regulates delivery of microvesicle cargo such as the membrane-type 1 matrix metalloprotease (MT1-MMP) to shedding microvesicles. MT1-MMP delivery to nascent microvesicles depends on the association of VAMP3 with the tetraspanin CD9 and facilitates the maintenance of amoeboid cell invasion. VAMP3-shRNA expression depletes shed vesicles of MT1-MMP and decreases cell invasiveness when embedded in cross-linked collagen matrices. Finally, we describe functionally similar microvesicles isolated from bodily fluids of ovarian cancer patients. Together these studies demonstrate the importance of microvesicle cargo sorting in matrix degradation and disease progression.


Subject(s)
Gene Expression Regulation, Neoplastic/physiology , Neoplasm Invasiveness , Neoplasms/blood supply , Neovascularization, Pathologic/metabolism , Animals , Cell Line , Cell Line, Tumor , Fluorescent Dyes , Humans , Melanoma , Protein Transport , Vesicle-Associated Membrane Protein 3/genetics , Vesicle-Associated Membrane Protein 3/metabolism
8.
Sci Signal ; 6(265): ra14, 2013 Mar 05.
Article in English | MEDLINE | ID: mdl-23462101

ABSTRACT

ß-Catenin has a dual function in cells: fortifying cadherin-based adhesion at the plasma membrane and activating transcription in the nucleus. We found that in melanoma cells, WNT5A stimulated the disruption of N-cadherin and ß-catenin complexes by activating the guanosine triphosphatase adenosine diphosphate ribosylation factor 6 (ARF6). Binding of WNT5A to the Frizzled 4-LRP6 (low-density lipoprotein receptor-related protein 6) receptor complex activated ARF6, which liberated ß-catenin from N-cadherin, thus increasing the pool of free ß-catenin, enhancing ß-catenin-mediated transcription, and stimulating invasion. In contrast to WNT5A, the guidance cue SLIT2 and its receptor ROBO1 inhibited ARF6 activation and, accordingly, stabilized the interaction of N-cadherin with ß-catenin and reduced transcription and invasion. Thus, ARF6 integrated competing signals in melanoma cells, thereby enabling plasticity in the response to external cues. Moreover, small-molecule inhibition of ARF6 stabilized adherens junctions, blocked ß-catenin signaling and invasiveness of melanoma cells in culture, and reduced spontaneous pulmonary metastasis in mice, suggesting that targeting ARF6 may provide a means of inhibiting WNT/ß-catenin signaling in cancer.


Subject(s)
ADP-Ribosylation Factors/physiology , Melanoma/pathology , Neoplasm Invasiveness , Neoplasm Metastasis , Proto-Oncogene Proteins/physiology , Transcriptional Activation/physiology , Wnt Proteins/physiology , beta Catenin/physiology , ADP-Ribosylation Factor 6 , Gene Silencing , Humans , Signal Transduction , Wnt-5a Protein , beta Catenin/metabolism
9.
Mol Biol Cell ; 23(23): 4495-505, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23051733

ABSTRACT

Epithelial cysts comprise the structural units of the glandular epithelium. Although glandular inversion in epithelial tumors is thought to be a potential mechanism for the establishment of metastatic disease, little is known about the morphogenic cues and signaling pathways that govern glandular polarity and organization. Using organotypic cultures of Madin-Darby canine kidney cells in reconstituted basement membrane, we show that cellular depletion of the small GTP-binding protein ARF6 promotes the formation of inverted cysts, wherein the apical cell membrane faces the cyst exterior, and the basal domain faces the central lumen, while individual cell polarity is maintained. These cysts are also defective in interactions with laminin at the cyst-matrix interface. This inversion of glandular orientation is accompanied by Rac1 inactivation during early cystogenesis, and temporal activation of Rac1 is sufficient to recover the normal cyst phenotype. In an unnatural collagen I microenvironment, ARF6-depleted, inverted epithelial cysts exhibit some loss of cell polarity, a marked increase in Rho activation and Rac1 inactivation, and striking rearrangement of the surrounding collagen I matrix. These studies demonstrate the importance of ARF6 as a critical determinant of glandular orientation and the matrix environment in dictating structural organization of epithelial cysts.


Subject(s)
ADP-Ribosylation Factors , Cell Polarity/genetics , Cellular Microenvironment/genetics , rac1 GTP-Binding Protein , ADP-Ribosylation Factor 6 , ADP-Ribosylation Factors/genetics , ADP-Ribosylation Factors/metabolism , Animals , Cell Membrane , Collagen/metabolism , Cysts/metabolism , Dogs , Epithelial Cells/cytology , Epithelial Cells/metabolism , Humans , Laminin/metabolism , Madin Darby Canine Kidney Cells , Neoplasms, Glandular and Epithelial/genetics , Neoplasms, Glandular and Epithelial/metabolism , Peptide Fragments/metabolism , RNA, Small Interfering , Signal Transduction , rac1 GTP-Binding Protein/genetics , rac1 GTP-Binding Protein/metabolism
10.
Mol Biol Cell ; 22(23): 4513-26, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21976699

ABSTRACT

Patterning of the Drosophila pupal eye is characterized by precise cell movements. In this paper, we demonstrate that these movements require an Arf regulatory cycle that connects surface receptors to actin-based movement. dArf6 activity-regulated by the Arf GTPase-activating proteins (ArfGAPs) dAsap and dArfGAP3 and the Arf GTP exchange factors Schizo and dPsd-promoted large cellular extensions; time-lapse microscopy indicated that these extensions presage cell rearrangements into correct epithelial niches. During this process, the Drosophila eye also requires interactions between surface Neph1/nephrin adhesion receptors Roughest and Hibris, which bind the adaptor protein Cindr (CD2AP). We provide evidence that Cindr forms a physical complex with dArfGAP3 and dAsap. Our data suggest this interaction sequesters ArfGAP function to liberate active dArf6 elsewhere in the cell. We propose that a Neph1/nephrin-Cindr/ArfGAP complex accumulates to limit local Arf6 activity and stabilize adherens junctions. Our model therefore links surface adhesion via an Arf6 regulatory cascade to dynamic modeling of the cytoskeleton, accounting for precise cell movements that organize the functional retinal field. Further, we demonstrate a similar relationship between the mammalian Cindr orthologue CD2AP and Arf6 activity in cell motility assays. We propose that this Cindr/CD2AP-mediated regulation of Arf6 is a widely used mechanism in emerging epithelia.


Subject(s)
Body Patterning/physiology , Drosophila Proteins/metabolism , Drosophila/growth & development , Epithelium/growth & development , Eye/cytology , Microfilament Proteins/metabolism , ADP-Ribosylation Factors/genetics , ADP-Ribosylation Factors/metabolism , Actins/metabolism , Adherens Junctions/metabolism , Animals , Animals, Genetically Modified , Cell Adhesion Molecules, Neuronal/genetics , Cell Adhesion Molecules, Neuronal/metabolism , Cell Movement , Drosophila Proteins/genetics , Eye/growth & development , Eye Proteins/genetics , Eye Proteins/metabolism , Guanine Nucleotide Exchange Factors/genetics , Guanine Nucleotide Exchange Factors/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Pupa
11.
Semin Cell Dev Biol ; 22(1): 39-47, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20837153

ABSTRACT

A wide range of cellular activities depends upon endocytic recycling. ARF6, a small molecular weight GTPase, regulates the processes of endocytosis and endocytic recycling in concert with various effector molecules and other small GTPases. This review highlights three critical processes that involve ARF6-mediated endosomal membrane trafficking-cell motility, cytokinesis, and cholesterol homeostasis. In each case, the function of ARF6-mediated trafficking varies-including localization of specific protein and lipid cargo, regulation of bulk membrane movement, and modulation of intracellular signaling. As described in this review, mis-regulation of endocytic traffic can result in human disease when it compromises the cell's ability to regulate cell movement and invasion, cell division, and lipid homeostasis.


Subject(s)
ADP-Ribosylation Factors/metabolism , Cell Division , Cell Movement , Endocytosis , Homeostasis , Lipids/physiology , ADP-Ribosylation Factor 6 , Animals , Humans
12.
J Cell Sci ; 123(Pt 10): 1603-11, 2010 May 15.
Article in English | MEDLINE | ID: mdl-20445011

ABSTRACT

Microvesicles are generated by the outward budding and fission of membrane vesicles from the cell surface. Recent studies suggest that microvesicle shedding is a highly regulated process that occurs in a spectrum of cell types and, more frequently, in tumor cells. Microvesicles have been widely detected in various biological fluids including peripheral blood, urine and ascitic fluids, and their function and composition depend on the cells from which they originate. By facilitating the horizontal transfer of bioactive molecules such as proteins, RNAs and microRNAs, they are now thought to have vital roles in tumor invasion and metastases, inflammation, coagulation, and stem-cell renewal and expansion. This Commentary summarizes recent literature on the properties and biogenesis of microvesicles and their potential role in cancer progression.


Subject(s)
Cell Communication , Cell-Derived Microparticles/metabolism , Neoplasms/pathology , Neoplasms/physiopathology , Animals , Biomarkers, Tumor/metabolism , Blood Coagulation , Cell Transformation, Neoplastic , Cell-Derived Microparticles/immunology , Cell-Derived Microparticles/pathology , Disease Progression , Drug Resistance, Neoplasm , Humans , Lipid Metabolism , Neoplasm Invasiveness , Neoplasms/blood supply , Neovascularization, Pathologic , Oncogenes , Tumor Escape
SELECTION OF CITATIONS
SEARCH DETAIL
...